Full-Time

QC Associate II

ElevateBio

ElevateBio

201-500 employees

Develops and commercializes cell and gene therapies

Industrial & Manufacturing

Junior, Mid

Waltham, MA, USA

Required Skills
Data Analysis
Requirements
  • Bachelor's or Master's degree in a technical discipline (Biology/Molecular Biology/Chemistry or related field) with a minimum of 3 years of experience, or 2 years with Master's degree, preferably in a GMP QC laboratory setting.
  • Experience with cell and gene therapy test methodologies (qPCR/ddPCR, Flow Cytometry, ELISA, and cell-based assays).
  • Excellent organizational skills and attention to detail.
  • Ability to work independently and communicate/collaborate with scientific/technical personnel.
  • Experience performing laboratory investigations.
  • Knowledge of GMPs, SOPs, and Quality System processes.
  • Experience working with electronic systems (LIMS, CMMS, QMS, ERP) is a plus.
Responsibilities
  • Perform routine analytical tests, analyze results, and record data/report in LIMS.
  • Investigate and review analytical testing excursions, including deviations, CAPAs and OOSs.
  • Collaborate with other QC functions to ensure all testing is completed within established timelines.
  • Work cross-functionally with QC Analytical Development to assist in the qualification and transfer of developed assays.
  • Draft test methods/SOPs.
  • Assist in the training of laboratory staff.

ElevateBio stands out as a leader in the cell and gene therapy industry, with its unique integration of diverse technology platforms such as gene editing and cellular engineering, and its state-of-the-art facilities. The company's BaseCamp manufacturing platform offers process innovation and cGMP manufacturing capabilities, enabling the production of viral vectors, RNA, and cell therapies. With a team of industry-leading experts and a commitment to accelerating the development of transformative therapies, ElevateBio is not only expanding its collaborations with industry partners but also actively developing its own portfolio of cellular and genetic medicines.

Company Stage

Series D

Total Funding

$1.2B

Headquarters

Waltham, Massachusetts

Founded

2017

Growth & Insights
Headcount

6 month growth

-3%

1 year growth

10%

2 year growth

32%